{
    "clinical_study": {
        "background": {
            "reference": {
                "citation": "Neuropsychopharmacology, 1996; 14(3) pp 187-193. Neruopsychopharmacology 1996; 14(3), 187-193", 
                "medline_ui": null
            }
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal."
        }, 
        "brief_title": {
            "textblock": "Neurobiology of Opioid Dependence: 2 - 2"
        }, 
        "condition": "Opioid-Related Disorders", 
        "contact": {
            "email": "marc.rosen@yale.edu", 
            "name": "Marc I Rosen, M.D.", 
            "phone": "(203)932-5711", 
            "phone_ext": "2112"
        }, 
        "design": [
            "Treatment", 
            "Double Blind", 
            "Placebo Control"
        ], 
        "detailed_descr": {
            "textblock": null
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "expected_enrollment": "0", 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "patients": null
        }, 
        "end_date": {
            "date": null
        }, 
        "initial_release_date": "1999-09-20", 
        "intervention": {
            "intervent_type": "Drug", 
            "primary_name": "Gamma hydroxybutyric"
        }, 
        "investigator": {
            "affiliation": {
                "agency": "VA Connecticut Healthcare System"
            }, 
            "name": "Marc I Rosen, M.D.", 
            "role": "Principal Investigator"
        }, 
        "keyword": null, 
        "last_data_entry_date": {
            "date": "1996-10"
        }, 
        "last_follow_up_date": {
            "date": null
        }, 
        "last_release_date": "2005-06-23", 
        "location": {
            "contact": {
                "email": "marc.rosen@yale.edu", 
                "name": "Marc I Rosen, M.D.", 
                "phone": "203-932-5711", 
                "phone_ext": "2112"
            }, 
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06519"
                }, 
                "name": "VA Connecticut Healthcare System"
            }, 
            "status": "No longer recruiting"
        }, 
        "official_title": {
            "textblock": "Neurobiology of Opioid Dependence: 2"
        }, 
        "oversight_info": {
            "regulatory_authority": "United States: Federal Government"
        }, 
        "phase_block": {
            "phase": "Phase 2"
        }, 
        "primary_outcome": [
            "Behavioral, subjective, measures of naloxone-preci", 
            "Phsyiological, neuroendocrine measures of naloxone"
        ], 
        "start_date": {
            "date": "1996-01"
        }, 
        "status_block": {
            "date": "1996-10", 
            "status": "Completed"
        }, 
        "study_id": {
            "nct_id": "NCT00000193", 
            "org_full_name": "National Institute on Drug Abuse (NIDA)", 
            "org_name": "NIDA", 
            "org_study_id": "NIDA-00191-2", 
            "secondary_id": "K20-00191-2"
        }, 
        "study_sponsor": {
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)"
            }, 
            "sponsor": {
                "agency": "Yale University"
            }
        }, 
        "study_type": "Interventional"
    }
}